Quick answers
- What is Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous used for?
- The FDA-approved label (TPN Electrolytes, Hospira, Inc., May 25, 2026) says: “TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous have a boxed warning?
- No. None of the 1 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous?
- 1 company lists prescription products of Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous in the FDA NDC Directory, including Hospira, Inc..
What Sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.
— FDA label: TPN Electrolytes, Hospira, Inc., effective May 25, 2026. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution, concentrate |
|---|---|
| Route | Intravenous |
| Prescription products | 1 in the FDA NDC Directory |
| Brand names | Tpn Electrolytes |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Hospira, Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018895 TPN ELECTROLYTES IN PLASTIC CONTAINER | Hospira | July 20, 1984 | 12, latest June 12, 2014 2014: Manufacturing (CMC) · 2003: Manufacturing (CMC) · 2001: Manufacturing (CMC) |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 801451 |
|---|---|
| SPL set ID of the quoted label | c00817bc-7b62-4abe-0280-e7930eda3f94 |
| FDA labels (SPL) | 1 |
| FDA applications | NDA018895 |
| Active ingredients (FDA) | CALCIUM CHLORIDE / MAGNESIUM CHLORIDE / POTASSIUM CHLORIDE / SODIUM ACETATE / SODIUM CHLORIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — TPN Electrolytes, Hospira, Inc., effective May 25, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →